• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chronic Obstr Pulm Dis . Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Chronic Obstr Pulm Dis


. 2021 Oct 1.
doi: 10.15326/jcopdf.2021.0245. Online ahead of print.
Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019


Daniel A Puebla Neira[SUP] 1 [/SUP], Abigail Watts[SUP] 1 [/SUP], Justin Seashore[SUP] 1 [/SUP], Alexander Duarte[SUP] 1 [/SUP], Shawn P Nishi[SUP] 1 [/SUP], Efstathia Polychronopoulou[SUP] 2 [/SUP], Yong-Fang Kuo[SUP] 2 3 [/SUP], Jacques Baillargeon[SUP] 3 [/SUP], Gulshan Sharma[SUP] 1 3 [/SUP]



Affiliations

Abstract

Rationale: There is controversy concerning the association of chronic obstructive pulmonary disease (COPD) as an independent risk factor for mortality in patients hospitalized with Coronavirus Disease 2019 (COVID-19). We hypothesize that patients with COPD hospitalized for COVID-19 have increased mortality risk.
Objective: To assess whether COPD increased the risk of mortality among patients hospitalized for COVID-19.
Methods: Retrospective cohort analysis of patients with COVID-19 between February 10, 2020 and November 10, 2020 and hospitalized within 14 days of diagnosis. Electronic health records from US facilities (Optum COVID-19 data) were used.
Results: In our cohort of 31,526 patients, 3,030 (9.6%) died during hospitalization. Mortality in patients with COPD was higher than that of patients without COPD, 14.02% and 8.8%, respectively. Univariate [Odds Ratio (OR) 1.68; 95% Confidence Interval (CI) 1.54 -1.84] and multivariate (OR 1.33; 95% CI 1.18 - 1.50) analysis showed that patients with COPD had greater odds of death due to COVID-19 than patients without COPD. We found significant interactions between COPD and sex and COPD and age. Specifically, the increased mortality risk associated with COPD was observed among female (OR 1.62; 95% CI 1.36 - 1.95) but not male patients (OR 1.14; 95% CI 0.97 - 1.34); and in patients aged 40 to 64 (OR 1.42; 95% CI 1.07 - 1.90) and 65 to 79 (OR 1.48; 95% CI 1.23 - 1.78) years.
Conclusions: COPD is an independent risk factor for death in adults aged 40 to 79 years hospitalized with COVID-19 infection.

Keywords: COVID-19; Chronic Obstructive; Mortality; Pulmonary Disease.
 
Back
Top Bottom